Related content

Regulatory aspects of integration of pharmacogenetics into drug development

By R S.R.  

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 2, 2001-04 ,pp. : 67-69

Adis International

Access to resources Recommend Favorite

Cyclosporin and Organ Specific Toxicity: Clinical Aspects, Pharmacogenetics and Perspectives

By  

Current Clinical Pharmacology, Vol. 3, Iss. 3, 2008-09 ,pp. : 166-173

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics, Regulation and Structural Properties of the Drugmetabolizing Enzymes Arylamine N-acetyltransferases

By  

Current Pharmacogenomics, Vol. 2, Iss. 4, 2004-01 ,pp. : 333-338

Bentham Science Publishers

Access to resources Recommend Favorite

Structural and Functional Aspects of Class A Carbapenemases

By  

Current Drug Targets, Vol. 17, Iss. 9, 2016-07 ,pp. : 1006-1028

Bentham Science Publishers

Access to resources Recommend Favorite

Structural Aspects of Peptides with Immunomodulating Activity

By  

Mini Reviews in Medicinal Chemistry, Vol. 7, Iss. 8, 2007-08 ,pp. : 861-870

Bentham Science Publishers

Access to resources Recommend Favorite